Clinical trial
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
NCT07199088 is registered in ClinicalTrials.gov with University of Health Sciences Lahore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
- Lead sponsor
- University of Health Sciences Lahore
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 11, 2025
- Completion date
- October 30, 2026
- Enrollment
- 320 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute decompensated heart failure, heart failure, diastolic, heart failure, systolic